Press Releases
🇺🇸 FDA Page 11FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Access critical pharma & biotech press releases. Stay ahead on drug approvals, clinical trials, M&A, and regulatory updates impacting global markets.
Showing 121–132 of 212 articles
AbbVie Receives FDA Complete Response Letter for TrenibotulinumtoxinE (TrenibotE) Manufacturing Issues
Alpha Tau Receives FDA Approval to Expand Alpha DaRT Pancreatic Cancer Trial with Gemcitabine-Abraxane Combination
Capricor Therapeutics HOPE-3 Phase 3 Trial Results for Deramiocel in Duchenne Muscular Dystrophy to be Presented at AAN 2026
Dupixent Becomes First Biologic Approved for Chronic Spontaneous Urticaria in Children Ages 2-11
OSE Immunotherapeutics' Tedopi Ovarian Cancer Trial Results Selected for ASCO 2026 Presentation
Nectero Therapeutics Reports Positive Two-Year Safety Data for EAST System in Abdominal Aortic Aneurysm Trial
Novo Nordisk's Oral Semaglutide Shows Promise as First GLP-1 Therapy for Children with Type 2 Diabetes
Greenwich LifeSciences GLSI-100 Abstract Accepted at ASCO 2026 for Breast Cancer Immunotherapy Trial
Mabwell's 9MW2821 Becomes First Nectin-4 ADC to Enter Phase III Trial for Triple-Negative Breast Cancer
ClearPoint Neuro Receives FDA Clearance for Velocity Alpha MR High Speed Surgical Drill System
Avaí Bio Receives First FDA Clearance for Cellular Rejuvenation Trial as Anti-Aging Market Reaches $120 Billion
Cipla Receives FDA Approval for First Generic Ventolin HFA (Albuterol Sulfate) - AB-Rated Therapeutic Equivalent